Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Envafolimab (ASC 22) is a humanized monoclonal antibody targeting programmed cell death ligand-1 (PD-L1), with antitumor activity. It blocks the interaction between PD-L1 and PD-1, and is used in studies of solid tumors.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $213 | In Stock | |
| 5 mg | $562 | In Stock | |
| 10 mg | $893 | In Stock | |
| 25 mg | $1,320 | In Stock | |
| 50 mg | $1,780 | In Stock | 
| Description | Envafolimab (ASC 22) is a humanized monoclonal antibody targeting programmed cell death ligand-1 (PD-L1), with antitumor activity. It blocks the interaction between PD-L1 and PD-1, and is used in studies of solid tumors.  | 
| In vitro | Envafolimab can inhibit the growth of gastric cancer cells with low PD-L1 expression by down-regulating DDX20 expression and regulating NFκB/TNF-α signaling pathway. [1]  | 
| Synonyms | KN035, KN 035, ASC22, ASC 22 | 
| Cas No. | 2102192-68-5 | 
| Color | Transparent | 
| Appearance | Liquid | 
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.